Skip to main content
10x Genomics, Inc. (TXG)
NASDAQ: TXG · IEX Real-Time Price · USD
16.70
+0.14 (0.85%)
At close: Jul 19, 2024, 4:00 PM
17.40
+0.70 (4.19%)
Pre-market: Jul 22, 2024, 7:25 AM EDT

10x Genomics Revenue

10x Genomics had revenue of $625.45M in the twelve months ending March 31, 2024, with 16.64% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $141.01M with 5.01% year-over-year growth. In the year 2023, 10x Genomics had annual revenue of $618.73M with 19.81% growth.

Revenue (ttm)
$625.45M
Revenue Growth
+16.64%
P/S Ratio
3.20
Revenue / Employee
$496,782
Employees
1,259
Market Cap
2.00B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020298.85M52.95M21.53%
Dec 31, 2019245.89M99.58M68.06%
Dec 31, 2018146.31M75.23M105.83%
Dec 31, 201771.09M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BrightSpring Health Services 9.37B
Premier 1.34B
NovoCure 525.66M
Catalyst Pharmaceuticals 411.35M
Protagonist Therapeutics 314.95M
Immunocore Holdings 264.25M
Recursion Pharmaceuticals 46.24M
Revenue Rankings

TXG News

More News